DHI vs SYRE · P/E 9.6, rev $34.25B vs $7.60B cap
DR Horton Inc (DHI) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the DHI and SYRE stock pages for the full models.
Not investment advice.